Benjamin L Palleiko, the CHIEF EXECUTIVE OFFICER of $KALV, sold 6,669 shares of the company on 03-07-2025 for an estimated $79,827. We received data on the trade from a recent SEC filing. This was a sale of approximately 2.3% of their shares of this class of stock. Following this trade, they now own 287,811 shares of this class of $KALV stock.
$KALV Insider Trading Activity
$KALV insiders have traded $KALV stock on the open market 21 times in the past 6 months. Of those trades, 8 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $KALV stock by insiders over the last 6 months:
- HEALTHCARE CAPITAL PARTNERS III, L.P. VENROCK has made 8 purchases buying 336,212 shares for an estimated $3,087,433 and 0 sales.
- BENJAMIN L PALLEIKO (CHIEF EXECUTIVE OFFICER) has made 0 purchases and 5 sales selling 41,152 shares for an estimated $427,249.
- PAUL K. AUDHYA (CHIEF MEDICAL OFFICER) has made 0 purchases and 4 sales selling 15,783 shares for an estimated $151,040.
- CHRISTOPHER YEA (CHIEF DEVELOPMENT OFFICER) has made 0 purchases and 4 sales selling 13,674 shares for an estimated $130,722.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$KALV Hedge Fund Activity
We have seen 70 institutional investors add shares of $KALV stock to their portfolio, and 58 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- OCTAGON CAPITAL ADVISORS LP added 1,370,000 shares (+inf%) to their portfolio in Q4 2024, for an estimated $11,603,900
- FRAZIER LIFE SCIENCES MANAGEMENT, L.P. added 1,200,000 shares (+32.5%) to their portfolio in Q4 2024, for an estimated $10,164,000
- ADAGE CAPITAL PARTNERS GP, L.L.C. removed 1,119,792 shares (-78.9%) from their portfolio in Q4 2024, for an estimated $9,484,638
- STEMPOINT CAPITAL LP added 992,803 shares (+inf%) to their portfolio in Q4 2024, for an estimated $8,409,041
- MPM BIOIMPACT LLC removed 896,915 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $7,596,870
- VESTAL POINT CAPITAL, LP added 770,000 shares (+19.2%) to their portfolio in Q4 2024, for an estimated $6,521,900
- SUVRETTA CAPITAL MANAGEMENT, LLC added 701,007 shares (+16.6%) to their portfolio in Q4 2024, for an estimated $5,937,529
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
